Form 4 holding
Chief Scientific Officer
Cartesian Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 62,490
- Estimated value
- $201,843
- Report date
- 10 Jan 2025
- Price
- $3.23
- Ownership
- Direct
Christopher M. Jewell - Chief Scientific Officer at Cartesian Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Scientific Officer
- Issuer ticker
- RNAC on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Christopher M. Jewell since 21 Aug 2025
Reported holdings for Christopher M. Jewell in Cartesian Therapeutics, Inc.
Form 4 holding
Chief Scientific Officer
Cartesian Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 67,432
- Estimated value
- $53,271
- Report date
- 10 Jan 2025
- Price
- $0.7900
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Scientific Officer
Cartesian Therapeutics, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 47,400
- Estimated value
- Report date
- 02 Jan 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Christopher M. Jewell in Cartesian Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.